EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting ferroptosis in major digestive system malignancies: regulatory networks and therapeutic opportunities

Xiaoguang Qin, Qingna Wen, Yufei Yang, Kai Sun, Wenjing Guan, Lingna Ma, Penghui Sun, Ming Zhang, Yana Wu, Linzhu Li, Kaikai Wang

Frontiers in Cell and Developmental Biology · 29.10.2026 · 14

DOI: 10.3389/fcell.2026.1945918 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 29.10.2026. Verfasst von Xiaoguang Qin und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Acupuncture-Moxibustion and Tuina, Gansu University of Chinese Medicine, Lanzhou, Gansu Province, China. Die Arbeit nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis is an iron-dependent form of regulated cell death that is associated with the accumulation of lipid peroxides, particularly in polyunsaturated fatty acids (PUFAs)-containing cellular membranes. Ferroptosis is initiated by aberrant iron metabolism, intense reactive oxygen species (ROS) production, oxidative damage to membrane structures and disruption of the cystine/glutamate antiporter system (System Xc − )–glutathione (GSH)–glutathione peroxidase 4 (GPX4) antioxidant pathway. Emerging evidence increasingly recognizes ferroptosis as a crucial mediator of tumor progression and response to therapy in digestive system malignancies. Aberrant iron homeostasis, lipid metabolic reprogramming, redox imbalance and remodeling of the tumor microenvironment (TME) are common events found in digestive system malignancies. This structured narrative review primarily focuses on colorectal cancer (CRC), hepatocellular carcinoma (HCC), gastric cancer (GC), and pancreatic ductal adenocarcinoma (PDAC) because ferroptosis regulatory mechanisms have been best defined for these cancers with respect to tumor-intrinsic regulation, metabolic vulnerability, antioxidant dependency, TME interactions and therapeutic responses. Additional evidence assessing whether the regulatory principles of ferroptosis extend to additional digestive system malignancies such as esophageal squamous-cell carcinoma and extrahepatic cholangiocarcinoma is also presented. Collectively, these modifications contribute to ferroptosis sensitivity as well as tumor growth, treatment resistance and immune evasion. Ferroptosis is not simply regulated by a single linear pathway, but rather orchestrated through multilayered regulatory networks involving transcriptional and epigenetic control, metabolic rewiring, immune modulation, exosome-mediated communication and extensive crosstalk between numerous signaling pathways. The application of ferroptosis inducers, nano-platform delivery systems, TME-responsive methodology and multimodal combination schemes indicates emerging therapeutic approaches with potential translational implications for digestive system malignancies. Nonetheless, clinical translation is limited by mechanistic complexity, tumor heterogeneity, incompletely defined resistance mechanisms, uncertainty of reliable predictive biomarkers and unaddressed biosafety issues with nanoplatforms. Thus, this Review frames current evidence within a three-tier mechanistic-to-translational framework that connects a common iron–lipid–redox vulnerability axis possessing tumor-type-specific resistance programs and biomarker-directed therapeutic prioritization to delineate context-dependent ferroptosis vulnerabilities and priorities for future clinical evaluation.

Schlagwörter

Stichwörter der Autor:innen

digestive system malignanciesferroptosislipid peroxidationtargeted therapytumor microenvironment

Autor:innen und Institutionen

  • College of Acupuncture-Moxibustion and Tuina, Gansu University of Chinese Medicine, Lanzhou, Gansu Province, China.
  • Higher Vocational and Technical College, Henan Institute of Science and Technology, Xinxiang, Henan Province, China.
  • School of Public Health, Gansu University of Chinese Medicine, Lanzhou, Gansu Province, China.
  • The First Clinical Medical School, Henan University of Chinese Medicine, Zhengzhou, Henan Province, China.
  • Department of Hematology and Oncology, Henan Integrative Medicine Hospital, Zhengzhou, Henan Province, China.
  • College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.

Zitieren

APA

Qin, X., Wen, Q., Yang, Y., Sun, K., Guan, W., Ma, L., Sun, P., Zhang, M., Wu, Y., Li, L., & Wang, K. (2026). Targeting ferroptosis in major digestive system malignancies: regulatory networks and therapeutic opportunities. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1945918

Vancouver

Qin X, Wen Q, Yang Y, Sun K, Guan W, Ma L, et al. Targeting ferroptosis in major digestive system malignancies: regulatory networks and therapeutic opportunities. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1945918

BibTeX
@article{Qin2026,
  author = {Qin, Xiaoguang and Wen, Qingna and Yang, Yufei and Sun, Kai and Guan, Wenjing and Ma, Lingna and Sun, Penghui and Zhang, Ming and Wu, Yana and Li, Linzhu and Wang, Kaikai},
  title = {Targeting ferroptosis in major digestive system malignancies: regulatory networks and therapeutic opportunities},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fcell.2026.1945918}
}
Kostenlos starten →